Steven M. Fruchtman
2023
In 2023, Steven M. Fruchtman earned a total compensation of $1.1M as President and Chief Executive Officer at Onconova Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Bonus | $232,503 |
|---|---|
| Option Awards | $131,662 |
| Salary | $660,288 |
| Stock Awards | $50,613 |
| Other | $26,339 |
| Total | $1,101,404 |
Fruchtman received $660.3K in salary, accounting for 60% of the total pay in 2023.
Fruchtman also received $232.5K in bonus, $131.7K in option awards, $50.6K in stock awards and $26.3K in other compensation.
Rankings
In 2023, Steven M. Fruchtman's compensation ranked 1,111th out of 3,006 executives tracked by ExecPay. In other words, Fruchtman earned more than 63.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,111 out of 3,006 | 63rd |
Division Manufacturing | 661 out of 1,650 | 60th |
Major group Chemicals And Allied Products | 450 out of 918 | 51st |
Industry group Drugs | 439 out of 881 | 50th |
Industry Pharmaceutical Preparations | 301 out of 637 | 53rd |
Source: SEC filing on October 11, 2024.
Fruchtman's colleagues
We found two more compensation records of executives who worked with Steven M. Fruchtman at Onconova Therapeutics in 2023.
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019